UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): May 22 2009
UNITED ECOENERGY CORP.
(Exact Name of Registrant as Specified in Its Charter)
Nevada 814-00717 84-1517723
(State or Other Jurisdiction (Commission File Number) I.R.S. Employer
of Incorporation) Identification No.)
1365 N. Courtenay Parkway, Suite A
Merritt Island, FL 32953
(Address of principal executive offices) (Zip Code)
(321)-452-9091)
(Issuer's telephone number)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (See General Instruction A.2 below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Section 1 - Registrant?s Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
Om May 22, 2009, the Company entered into an Agreement for the acquisition of
the assets of Epic Wound Care, LLC as a portfolio investment of the Company. A
new corporation, Epic Wound Care, Inc., will be incorporated to acquire the
assets and operate the business, and will be a wholly-owned subsidiary of the
Company. The transaction is expected to close during the first week of June,
2009.
Under the Agreement, the Company will issue a total of 30 million common shares
in escrow, with 10 million shares released at closing, and the remaining 20
million shares to be released on meeting certain specified performance
criteria. Epic Wound Care LLC manufactures and distributes its proprietary
products under its own label, HymoStyp?, and its distributor?s trademarks,
ActCel?, ActJel?, and ABC Gauze?. The gauze is a natural product for use in
any wound site where bleeding is still present. Upon contact with moisture,
the gauze breaks down to form a gel-like substance that acts as a hemostatic
agent to stop bleeding. Once bleeding has been stopped and coagulation has
occurred, the product is then rinsed away with saline solution or lukewarm
water. Epic Wound Care LLC currently has an established distribution
network with a worldwide customer base, anchored by Coreva Health Science,
and is expanding its marketing efforts into the US and European retail
sectors.
SECTION 9. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements.
----------------------
None.
(b) Exhibits.
None
This report on Form 8-K may contain forward-looking statements that
involve risks and uncertainties, as well as assumptions that, if they never
materialize or prove incorrect, could cause the results of the Company to
differ materially from those expressed or implied by such forward-looking
statements. All statements other than statements of historical fact are
statements that could be deemed forward-looking statements, including any
projections of revenue, expenses, earnings or losses from operations or
investments, or other financial items; any statements of the plans,
strategies and objectives of management for future operations; any
statements of expectation or belief; and any statements of assumptions
underlying any of the foregoing. The risks, uncertainties and assumptions
referred to above include risks that are described from time to time in our
Securities and Exchange Commission, or the SEC, reports filed before this
report.
We use words such as anticipates, believes, expects, future, intends and
similar expressions to identify forward-looking statements. Our actual
results could differ materially from those projected in the forward-looking
statements for any reason. We caution you that forward-looking statements of
this type are subject to uncertainties and risks, many of which cannot be
predicted or quantified.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by
the undersigned duly authorized officer.
Date: June 1, 2009
UNITED ECOENERGY CORP.
By /s/ Kelly T. Hickel
--------------------------------
Kelly T. Hickel
Chief Executive Officer
5